Focus on primary care periodontal disease: Implications for women's health

Obstetrical and Gynecological Survey

Volumn 56, Issue 1, 2001, Pages 43-49

  Zeeman, Gerda G ^a,c   Veth, E Olaf ^b   Dennison, David K ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Southwestern Medical Center ^*

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GINGIVITIS; HUMAN; MENOPAUSE; ORAL CONTRACEPTION; OSTEOPOROSIS; PERIODONTAL DISEASE; PREGNANCY; PREMATURE LABOR; PUBERTY; REVIEW; RISK FACTOR;

EID: 0035183705     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-200101000-00024     Document Type: Review

References (78)

1. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994
2. Prevention of infective endocarditis
3. Experimental transient bacteremias in human subjects with varying degrees of plaque accumulation and gingival inflammation
4. Relationship of bacteremia and tooth brushing in patients with periodontitis
5. Host responses in periodontal disease
6. The interleukin-1 genotype as a severity factor in adult periodontal disease
7. Influence of risk factors on the pathogenesis of periodontitis
8. Periodontal diseases: Epidemiology
9. 2, IL-1βb, and TNF-αa responses in diabetics as modifiers of periodontal disease expression
10. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss
11. Assessment of risk for periodontal disease. II Risk indicators for alveolar bone loss
12. Periodontal disease
13. Oral disease, cardiovascuar disease, and systemic inflammation
14. Periodontal disease and risk for myocardial infarction and cardiovascular disease
15. Healthy gums for a happy heart
16. Dental disease and risk of coronary heart disease and mortality
17. Periodontal disease is a predictor of cardiovascular disease in a native American population
18. Periodontal disease and cardiovascular disease
19. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegaly virus
20. Periodontal disease and coronary heart disease risk
21. How periodontal disease may contribute to cardiovascular disease
22. Effects of oral flora on platelets: Possible consequences in cardiovascular disease
23. Type 2 diabetes mellitus and periodontal disease
24. Periodontal disease in non-insulin-dependent diabetes mellitus
25. Periodontal disease and NIDDM in Pima Indians
26. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes)
27. Periodontal conditions in insulin-dependent diabetes mellitus
28. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus
29. Glycemic control and alveolar bone loss progression in type 2 diabetes
30. The relationship between reduction in periodontal inflammation and diabetes control: A report of 9 cases
31. Periodontal disease and diabetes mellitus: A two-way relationship
32. Diabetes and periodontal diseases
33. Hyperglycemia, glycoxidation, and receptor for advanced glycation endproducts: Potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis
34. Specific estrogen receptors in human gingiva
35. Hormonal influences on gingival tissue: Relationship to periodontal disease
36. Influence of hormonal variation on the periodontium in women
37. Effect of oral contraceptive therapy on gingival inflammation in humans
38. Periodontal condition of pregnant women assessed by CPTIN
39. Androgens modulate interleukin-6 production by gingival fibroblasts in vitro
40. The subgingival microbial flora during pregnancy
41. Effects of estradiol and progesterone on Bacteroides melanogenicus and Bacteroides gingivalis
42. A longitudinal study of gingivitis and puberty
43. A longitudinal study from prepuberty to puberty of gingivitis
44. Effects of oral contraceptives on the gingiva
45. Gingival exudation during the menstrual cycle
46. The influence of oral contraceptive therapy on the periodontium - Duration of drug therapy
47. Systemic osteoporosis and oral bone loss: Evidence show increased risk factors
48. Osteoporosis: A risk factor in periodontal disease
49. Osteoporosis. A possible modifying factor in oral bone loss
50. Postmenopausal bone loss and its relationship to oral bone loss
51. Periodontal status of women taking postmenopausal estrogen supplementation
52. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women
53. Post-menopausal hormone use and tooth loss: A prospective study
54. The benefits of estrogen replacement therapy on oral health: The Leisure World Cohort
55. Periodontal disease in pregnancy. I. Prevalence and severity
56. A longitudinal investigation of the periodontal changes during pregnancy and 15 months postpartum
57. Tooth mobility changes in pregnancy
58. Experimental gingivitis during pregnancy and postpartum: Clinical, endocrinological, and microbiological aspects
59. The effect of female sex hormones on subgingival plaque
60. CD4 to CD8 ratio and in vitro lymphoproliferative responses during experimental gingivitis in pregnancy and postpartum
61. Experimental gingivitis during pregnancy and postpartum: Immunohistochemical aspects
62. Maternal T lymphocyte response and gingivitis in pregnancy
63. Actinobacillus actinomycetemcomitans septicemia during pregnancy
64. Two fetal deaths associated with maternal sepsis and with thrombosis of the intervillous space of the placenta
65. Periodontal infection as a possible risk factor for preterm low birth weight
66. Poor periodontal health of the pregnant woman as a risk factor for low birth weight
67. Periodontal disease may pose one risk for premature birth
68. Premature labor. II. Bacterial sources of phospholipase
69. A review of premature births and subclinical infection
70. Control of cachectin (TNF) synthesis: Mechanism of endotoxin resistance
71. Detection of circulating tumor necrosis factor after endotoxin administration
72. Evidence for a common mechanism of action of interleukin 1-beta5, tumor necrosis factor-alpha, and epidermal growth factor on prostaglandin production in human chorion cells
73. Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua
74. Premature labor. I. Prostaglandin precursors in human placental membrane
75. Characterization of prostaglandin formation by human amnion cells in monolayer culture
76. Potential pathogenic mechanisms of periodontitis-associated pregnancy complications
77. Preterm birth: Associations with genital and possible oral microflora
78. Periodontal diseases: Pathogenesis